|
|
|
|
Model-Based Comparison of Cabotegravir Pharmacokinetics Following Thigh and Gluteal Injections
|
|
|
CROI 2024 March 3-6 Denver
Kelong Han1, Ronald D'Amico2, William Spreen2, Susan L. Ford3
1GSK, Collegeville, PA, United States; 2ViiV Healthcare, Durham, NC, United States; 3GSK, Durham, NC, United States
|
|
|
|
|
|
|